You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

Certaines de ces informations ou toutes, dans certains cas, n’apparaissent qu’en Anglais. Vous pouvez demander la version française

 

624 Results
Drug
Other Name(s): Alimta®
Quick Link(s): Drug Monograph, Patient Info Sheet
Dec 1969
Drug
Quick Link(s): Drug Monograph, Patient Info Sheet
Jan 2024
Drug
Other Name(s): Matulane®
Quick Link(s): Drug Monograph, Patient Info Sheet
Dec 1969
Drug
Other Name(s): Ifex® (multiple brands available)
Quick Link(s): Drug Monograph, Patient Info Sheet
Dec 1969
Drug
Other Name(s): Perjeta®
Quick Link(s): Drug Monograph, Patient Info Sheet
Sep 2022
Drug
Other Name(s): Zydelig™
Quick Link(s): Drug Monograph, Patient Info Sheet
Dec 1969
Drug
Other Name(s): Iclusig®
Quick Link(s): Drug Monograph, Patient Info Sheet
Sep 2020
Drug
Other Name(s): Ibrance™
Quick Link(s): Drug Monograph, Patient Info Sheet
Dec 1969
Drug
Other Name(s): Ninlaro™
Quick Link(s): Drug Monograph, Patient Info Sheet
Dec 1969
Regimen
Cancer Type:
Gastrointestinal, 
Gastrointestinal Stromal Tumours, 
Sarcoma, 
GIST
Show More Show more tags
, Show Less Show fewer tags
Intent: Adjuvant
Funding:
ODB - General Benefit
    iMAtinib - Refer to listed Health Canada indications for generic imatinib formulations. Patients must meet generic substitution policies for access to Gleevec®
Show More Show more tags
, Show Less Show fewer tags
Drugs Used:
iMAtinib
... Show more tags
, Collapse Show fewer tags
Quick Link(s):
Regimen Monograph
Oct 2024
Regimen
Cancer Type:
Gastrointestinal, 
Gastrointestinal Stromal Tumours, 
Sarcoma, 
GIST
Show More Show more tags
, Show Less Show fewer tags
Intent: Palliative
Funding:
ODB - General Benefit
    iMAtinib - Refer to listed Health Canada indications for generic imatinib formulations. Patients must meet generic substitution policies for access to Gleevec®
Show More Show more tags
, Show Less Show fewer tags
Drugs Used:
iMAtinib
... Show more tags
, Collapse Show fewer tags
Quick Link(s):
Regimen Monograph
Oct 2024
Regimen
Cancer Type:
Hematologic, 
Leukemia - Chronic Myeloid (CML)
Show More Show more tags
, Show Less Show fewer tags
Intent: Palliative
Funding:
ODB - General Benefit
    iMAtinib - Refer to listed Health Canada indications for generic imatinib formulations. Patients must meet generic substitution policies for access to Gleevec®
Show More Show more tags
, Show Less Show fewer tags
Drugs Used:
iMAtinib
... Show more tags
, Collapse Show fewer tags
Quick Link(s):
Regimen Monograph
Oct 2024

Pages